Jeremy VisserDec 8, 20211 min readVIDEO: New study shows AD patients on dupilumab may experience less severe Covid-19 symptomsPatients being treated with dupilumab for atopic dermatitis (AD) may experience less severe Covid-19 symptoms, according to a new study.
Patients being treated with dupilumab for atopic dermatitis (AD) may experience less severe Covid-19 symptoms, according to a new study.
VIDEO: Online mindfulness training shows improvement in QoL, severity for AD patientsOnline mindfulness training has shown improvements in patient QoL and disease severity in AD.